Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by MrMugsyon Sep 03, 2022 6:51pm
268 Views
Post# 34940391

Now - look at Wallace's work related to western diets ...

Now - look at Wallace's work related to western diets ...When you now look at the news about ultra-processed foods and you compare it to what Wallace was saying in 2021 about Aspriin-H2S ... you get a feeling for where this is going.

Just need to look at conclusion and discussion sections for confirmation that H2S can be a force in this space.

Not surprising !

This is the report that Wallace did with the Ukranian Scientists (may have already shared but now the contest is easier to see).

https://www.researchgate.net/publication/353201086_Hydrogen_Sulfi_de-releasing_anti-infl_ammatory_drug_ATB-340_treatment_potentially_reduces_mesenteric_metafl_ammation_in_the_experimental_age-and_high_fructose_dietary-induced_injury
<< Previous
Bullboard Posts
Next >>